Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts
Clinical trial NCT07498205 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07498205
- Sponsor
- SWOG Cancer Research Network
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-08
- Primary completion
- 2029-08-08
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.